mide. In normal guinea pigs anti-band 3 NOA significantly accelerated the clearance of erythrocytes that were mildly damaged by iodine surface labeling and of those that were further oxidized by diamide. However, the anti-band 3 effect was transient and small. In contrast, anti-band 3 NOA did not significantly alter erythrocyte survival in functionally C3-deficient guinea pigs, thereby supporting the C3b requirement for anti-band 3 NOA activii. On the other hand, a pretreatment of animals with purified human band 3 protein slowed down the clearance of erythrocytes incubated with IgG depleted of anti-band 3 NOA. These results provide the first in vivo evidence of a role for anti-band 3 NOA in the clearance of erythrocytes. toantibodies (NOAs), which facilitate the specific clearance of senescent cells by the macrophage system. NOAs directed against many conserved self-antigens have been found in sera from healthy humans and animals and have been shown to be exact translation copies of germ line Ig genes.13 The serum concentrations of NOAs are normally kept low, their affinities are 10-to 1,000-fold less than those of induced antibodies, and many are bi-or poly~pecific.'~ It has been hypothesized that NOAs are involved in the removal of senescent or altered self-antigens by providing specificity for these tissue homeostatic clearance mechanisms. Of the presently characterized NOAs against specific erythrocyte membrane constituents, anti-band 3 autoantibodies (anti-band 3 antibodies)14 appear most likely to be involved in opsonization, phagocytosis, and in vivo clearance of erythrocytes by extravascular hem~lysis.'~.'~ Despite the anti-band 3 antibodies' low concentration of 50 to 100 ng/mL serum in humans and their weak affinity to band 3 protein, with an estimated association constant of 5 X lo6 to 7 X lo6 L/rnol,l7 these antibodies apparently reach functionality by at least two additive mechanisms. Oligomerization of band 3 protein (without chemical modification) within the erythrocyte membrane allows for firm, bivalent binding of anti-band 3 IgCI8 to protein rather than to carbohydrate of band 3.19 Because senescent or oxidatively stressed erythrocytes contain band 3 oligomers,20~22 these antibodies preferentially bind in small amounts to Furthermore, after forming clusters on membranes, anti-band 3 antibodies not only initiate complement deposition, but preferentially form C3b-IgC complexe~?~ as they have a second binding affinity for C3 that is independent of the band 3 binding site. 17 In analogy to antigen-bound C3b-IgG complexes from induced antib~dies,'~.'~ C3b-anti-band 3 antibody complexes on erythrocytes represent strong opsonins and nucleate alternative C3 convertases, thereby further augmenting C3b deposition and leading to enhanced phagocytosis. However, the tissue homeostatic role of anti-band 3 antibodies in the selective opsonization and clearance of senescent and altered erythrocytes has not yet been documented in vivo.
In many inherited and acquired erythrocyte disorders, 31 Exposure of human erythrocytes to diamide also caused disulfide-linked band 3 proteins"; the preferential phagocytosis of these oxidatively stressed erythrocytes by adherent monocytes was dependent on the presence of serum and active complement3* and accelerated by the addition of anti-band 3 antibodies.'8 Because the oxidative damage by diamide is similar to changes observed in senescent erythrocytes, the mechanisms of in vivo clearance of senescent and oxidatively stressed erythrocytes may be similar.
Here we provide the first evidence that affinity-purified human anti-band 3 antibodies accelerate the clearance of labeled and oxidatively stressed erythrocytes in vivo. To demonstrate the effect of anti-band 3 antibodies, guinea pigs appeared to be most suitable for the following reasons: (1) Because only small quantities of purified anti-band 3 antibodies were available, small-sized animals, from which repeated blood samples could be conveniently obtained, were chosen. (2) Guinea pigs have previously been used to study antibody-mediated clearance of e r y t h r o~y t e s .~~*~~ (3) Complement component C3-deficient guinea pigs have recently been allowing the study of the role of complement on the effect of anti-band 3 antibodies in vivo.
MATERIALS AND METHODS

Guinea Pigs
Healthy 3-to 4-month-old Dunkin-Harley guinea pigs (Wiga, Zurich, Switzerland) and complement C3-deficient guinea pigs36 from the Robert Koch Institute in Berlin, Germany, were housed and used according to the guidelines of Zurich's Animal Care and Use Committee. For all blood collections and administrations, guinea pigs were anesthetized either by short ether inhalation or subcutaneous injection of 0.6 mg/kg ketamine and 6 mg/kg xylazine, and aseptic techniques were used. For in vitro labeling and treatment of erythrocytes, 4 mL of blood from normal guinea pigs was collected by intracardiac puncture with a 23-gauge needle and a syringe containing 0.2 mL 100 mmol/L EDTA. Labeled and treated erythrocytes in a volume of 0.2 to 0.25 mL were administered by slow injection through a 25-gauge needle into the left ventricle. To follow the survival of a mixture of labeled erythrocytes, 0.1 to 0.2 mL blood was repeatedly collected by retroorbital sinus puncture with sterile Pasteur pipettes containing 0.01 mL 100 mmol/L EDTA after 1, 3, 13, and 27 minutes; 1, 2, 5, and 10 hours; and on days 1, 2, 3, and 5. At the termination of an erythrocyte survival study animals were killed with intraperitoneal phenobarbital administration.
Labeling of Erythrocytes
For all in vitro procedures, sterile solutions and containers were used. After removal of white blood cells by a cellulose column37 and of plasma components by washing three times with 10 v01 of a phosphate-buffered saline (PBS) solution containing 0. 
Diamide Treatment of Erythrocytes and Deformability
Based on our in vitro human erythrocyte studies" and in vivo canine erythrocyte studies by Johnson et al," diamide was used to oxidatively stress erythrocytes. Aliquots of a freshly prepared 20 mmol/L diamide (Sigma) solution in 150 mmol/L NaCl were added to labeled or unlabeled 5% erythrocyte suspensions in HEPES buffer to reach a final concentration of 0 to 400 pmom. After a l-hour incubation at 37T, erythrocytes were washed three times in cold PBS-glucose and once in PBS-HSA before resuspending them at a hematocrit of 35% in PBS-HSA. Erythrocytes were counted with a Sysmex T-800 (TOA Medical Electronics, Japan). Deformability of labeled and unlabeled erythrocytes treated with various concentrations of diamide was assessed by an ektacytometer (Technicon, Hamburg, Germany) by using the osmoscan mode3* as we previously described for human erythrocytes?
Anti-Band 3 Antibodies and Their Binding to Cells and Blotted Protein
Naturally occumng anti-band 3 antibodies were affinity-purified from pooled human IgG (Sandoglobulin; provided by the Central Laboratory of the Swiss Transfusion Services) on columns with immobilized band 3 protein as previously de~cribed,'~ except that pooled IgG was first depleted of antiidiotypic and antispectrin antibodies as outlined e1~ewhere.I~ The unbound fraction representing human IgG depleted of anti-band 3 antibodies was used as an IgGcontrol.
For binding studies with erythrocytes from guinea pigs, human anti-band 3 antibodies were '*%iodinated using chloramine T as an oxidant to a specific activity ranging from 2.5 X lo7 to 6 X IO7 c p d p g IgG." Equal numbers (2 X lo') of packed, unlabeled guinea pig erythrocytes, previously treated with 0, 100,200, and 400 pmoU L diamide and washed once in binding buffer (10 mmol/L phosphate, 150 mmovL NaCI, 1 g/L D-glucose, 0.1 % gelatin, 2 mmovL MgCl, , pH 7.4), were mixed with 60 pL of binding buffer containing labeled anti-band 3 antibodies at 500 X 10' to 750 X lo' cpm, unlabeled anti-band 3 antibodies to achieve a given total concentration, 5% HSA, and 12.5 mg/mL human IgG. After incubation for 30 minutes at 37"C, the binding reaction was stopped by adding 120 pL of cold PBS-glucose containing 10 mmolR. EDTA, layering 150 pL of this suspension over 200 pL of a phthalate oil mixture [70% (voUvol) dibutyl-and 30% bis[3,5,5-trimethyl]-phthalate], and centrifuging for 4 minutes at 10,OOO rpm in a Beckman Microfuge I1 (Beckman Instruments, Geneva, Switzerland). The tubes were frozen in methanoUdry ice, and the tube tips containing the erythrocyte pellets were cut off and counted for radioactivity. Binding of anti-band 3 antibodies to guinea pig erythrocytes is given in nanograms per 1 o ' O cells and was calculated from bound label and the specific radioactivity of anti-band 3 antibodies.
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From For sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting, membranes from either labeled or unlabeled guinea pig erythrocytes that had been treated with 0 to 400 p m o m diamide were prepared and stored as previously described for human erythrocyte membranes." SDS-PAGE was performed with 7-pg aliquots of membrane protein that were unreduced or reduced with dithiothreitol and alkylated by N-ethylmaleimide as previously described." Gels were blotted onto nitrocellulose and then incubated with 100 ng/mL '"1-iodinated anti-band 3 antibodies (0.5 X lo6 to 0.7 X lo6 cpdmL) as outlined elsewhere." Bound radioactivity was shown by Phosphorlmager screens from Molecular Dynamics (Sunnyvale, CA).
Determination of In Vivo Clearance
Mixtures of '"1 and '"I surface-labeled erythrocytes were administered to determine the effect of anti-band 3 antibodies on the survival of untreated and diamide-treated cells in the same animal. On the day of allogeneic transfusions a mixture containing equal numbers of untreated and diamide-treated and differently labeled erythrocytes was prepared. Aliquots containing 3.5 X IO' to 5 X IO' cells of each type were incubated in vitro with either 20 pg/mL human anti-band 3 antibodies or control IgG-at a hematocrit of 20% to 25% in PBS-HSA at 37°C for 30 minutes immediately before injecting a total of 5 X 10' erythrocytes containing 8 X IO6 to 12 X IO6 cpm '"I and 2 X IO6 to 4 X lo6 cpm I3'I. Normal and C3-deficient guinea pigs were studied simultaneously. Where indicated, 4 hours before injection of labeled cells, animals received 200 pg of purified human band 3 protein,40 which was mixed with twice the amount of HSA and dialyzed extensively against PBS-glucose to deplete it of nonionic detergent before injection. Retroorbitally collected and EDTAanticoagulated blood was kept at 4°C until analyzed. Cell numbers were determined and radioactivity was measured on whole blood by adding 30 pL of anticoagulated blood to 200 pL of water and on similarly treated 30 pL of plasma with a gamma counter (MR480 Kontron, Zurich, Switzerland) using appropriate energy channels. The spillover of I3'I isotope into the ' "I channel was 40.6%. whereas the opposite spillover was negligible. Radioactivity in whole blood samples was referred to the actual cell numbers to correct for any changes of the hematocrit. At the same time, aliquots of the injected mixtures were also counted to correct for the decay of the iodine isotopes. This strategy also allowed an accurate determination of the initial counts of oxidatively stressed erythrocytes that were rapidly removed from the circulation. For untreated erythrocytes, we assigned the higher counts per minute value of the measurements at 1 and 3 minutes as the 100% value at time 0. The corresponding value for oxidatively stressed, labeled erythrocytes was calculated from the labeling ratio within the injected mixtures and the 100% value at time 0 for untreated control cells. The Student's t test was used to analyze the data, and a P value of less than .05 was considered statistically significant.
Plasma Anti-Band 3 Antibody Concentration
Our recently developed radioimmunoassay for human anti-band 3 was modified to detect guinea pig anti-band 3 antibodies in plasma or serum by capturing anti-band 3 antibodies on covalently immobilized band 3 protein4' and detecting bound antibodies with '=I-iodinated goat anti-guinea pig IgG (The Binding Site, Birmingham, UK). Binding was inhibitable to 50% to 60% by 200 pg/mL of fluidphase human band 3 protein. Intracardial administration of 200 pg human band 3 protein to normal guinea pigs lowered the inhibitable portion of the endogenous anti-band 3 antibody concentration by about 50% at 4 and 24 hours (averaged data from two animals not being transfused). 
RESULTS
In Vitro Erythrocyte Studies
Effect of diamide and labeling on erythrocyte defonnability. The deformability of erythrocytes from guinea pigs as assessed by the osmoscan mode with an ektacytometer ( Fig  1A) was similar to that of human erythrocytes. Exposure to increasing concentrations of the oxidative agent diamide gradually reduced the deformability to approximately 60% of control values, as indicated by the dose-dependent lowering of the osmoscans (Fig 1A) . Surface iodination with either isotope did not affect the deformability of otherwise untreated cells (Fig 1B) . As previously shown for other specie~:'.~~ the deformability of erythrocytes from guinea pigs was reduced by increasing concentrations of diamide. The diamide-induced reduction in deformability of either type of labeled erythrocytes (Fig 1B) was similar to that recorded for unlabeled cells (Fig 1A) . However, the right arms of the osmoscans of labeled and diamide-treated erythrocytes, were also markedly shifted to the left, indicating that these cells had lost a considerable amount of water and thereby became denser. This effect was likely caused by the isotopes or radicals within the solution, because identical incubating conditions without either isotope solution did not produce a left shift in the osmoscans. lmmunoblot with '%odinated, human anti-band 3 antibodies of membrane polypeptides from guinea pig erythrocytes that were exposed to the given concentrations of diamide. Unlabeled erythrocytes from guinea pigs were subjected to the radioiiodination procedure in the absence of radioisotopes, and then they were treated with diamide as indicated. Membranes were prepared as outlined, and equal amounts of membrane protein were run on SDS-PAGE in the presence (+) or the absence 1-1 of reducing agent. Membranes from untreated human erythrocytes containing roughly the same amount of protein were also electrophoresed and blotted (human). The polypeptides were transferred to nitrocellulose and immunoblotted with '251-labeled, human anti-band 3 antibodies. The dried blot was exposed to a Phosphorimager screen, and the digitized picture is shown. In addition to band 3 and band 4.2 protein, an adduct of band 3 protein with hemoglobin is marked (band 3-hb). The asterisks mark the high-molecular-weight protein complexes to which anti-band 3 antibodies bound.
Surface iodination of erythrocytes
by either isotope generated similar labeling patterns of membrane proteins (in particular, band 3; data not shown).
Human anti-hand 3 antihodv binding to hand 3 protein and to eytlrrocytes. Binding of labeled human anti-band 3 antibodies to membrane proteins from erythrocytes of guinea pigs and humans is shown on immunoblots in Fig 2. Naturally occurring anti-band 3 antibodies, affinity-purified from pooled human IgG, bound to blotted band 3 protein and band 4.2 (copurified antibodies) of membranes from erythrocytes. The degree of binding of human anti-band 3 antibodies to band 3 protein from guinea pigs was markedly less than to human band 3 protein, but still highly specific as it bound in the presence of 10 mg/mL unlabeled human IgG.
On blots from membranes of guinea pig erythrocytes exposed to diamide, a band above band 3 became evident that might represent a band 3-hemoglobin adduct (band 3-hb, Fig 2) .' Furthermore, three other high-molecular-weight proteins bound labeled anti-band 3 antibodies when membrane proteins were blotted from erythrocytes treated with increasing concentrations of diamide. Band 3-hb and other high-molecular-weight complexes could be completely reduced, whereby the anti-band 3 binding disappeared from highmolecular-weight complexes and was again confined to band 3 protein (Fig 2) . This supports the hypothesis that band 3 protein was bound through disulfide bridges in the highmolecular-weight complexes. In fact, the high-molecularweight complexes (Fig 2, marked with asterisks) had apparent molecular masses reminiscent of multiples of band 3 protein, thereby likely representing band 3 oligomers. Twodimensional gels with radiolabeled membranes run first unreduced and then reduced confirmed these results (data not shown). The binding of human labeled anti-band 3 antibodies to intact erythrocytes, measured by incubating erythrocytes from guinea pigs at physiologic conditions in the presence of SO mg/mL albumin and 10 mg/mL unlabeled human IgG, was dose-dependent ( 1 to 5 pg/mL) and enhanced by prior exposure of erythrocytes to diamide (Fig 3) .
In Vivo Entlrrocvte Studies
Clearance of iodinated er?,tkrocvtes and effect of diamide.
The survival of a mixture of I2'I or l 3 ' 1 surface-labeled erythrocytes, representing s1/100 of the animal's erythrocyte mass (S X 10' cells) of which one type of labeled cells was For personal use only. on October 27, 2017. by guest www.bloodjournal.org From exposed to diamide, was observed by repeated small blood sample collections. The apparent mean half-life of surfaceiodinated erythrocytes in guinea pigs was 8 days, independent of whether they were labeled with 1251 or I3lI. Furthermore, the erythrocyte survival in normal guinea pigs receiving autologous cells or normal and complement C3-deficient guinea pigs transfused with allogeneic erythrocytes was not different (data not shown). An apparent half-life of 8 days was considerably shorter than the previously published half-life of 42 days obtained by a cohort labeling with 59Fe", therefore, these cells must have been mildly damaged by the iodination process as shown under in vitro Erythrocyte Studies. Based on the negligible amount of plasma radioactivity (5 1 %), these cells were mostly cleared by extravascular hemolysis; however, partial or complete intravascular lysis of some erythrocytes cannot be ruled out. The halflives of diamide-treated erythrocytes ranged from 10 minutes to 20 hours (mean, 5 hours), and the diamide-induced shortening of the mean half-life of erythrocytes correlated with a reduction in mean cell deformability.
Effect of anti-band 3 antibodies in n o m 1 guinea pigs. Untreated and diamide-treated, labeled erythrocytes were incubated with either human anti-band 3 IgG or control IgG-(depleted of anti-band 3 antibodies) before administration of the mixture. The maximal plasma concentration achieved by the injection of approximately 5 pg anti-band 3 antibody per guinea pig was estimated to be 100 ng/mL, representing about twice the normal anti-band 3 concentration in humans. Anti-band 3 antibodies enhanced the clearance of erythrocytes, when compared with IgG-, in normal guinea pigs, whether the cells were mildly oxidized by the labeling procedure or heavily oxidized by exposure of labeled cells to diamide. Data from a typical experiment is shown in Fig 4, and averages from 11 experiments are shown in Fig 5. The difference in erythrocyte clearance between animals receiving anti-band 3 antibodies or control IgG-was evident in each of the 1 1 pairs of simultaneously studied guinea pigs, making the slightly accelerated clearance by anti-band 3 antibodies significant. However, this effect was relatively small and transient.
Effect of anti-band 3 antibodies in C3-deficient guinea pigs. Because anti-band 3-mediated phagocytosis of erythrocytes appears to be dependent on C3b,I8 we investigated the effect of anti-band 3 antibodies on the clearance of untreated and diamide-treated erythrocytes simultaneously in normal and complement C3-deficient guinea pig^.'^,^^ The survival of untreated and diamide-treated erythrocytes in C3-deficient and normal guinea pigs was similar (Figs 4 and 5) . Interestingly, exogenous anti-band 3 antibodies had no effect on the survival of erythrocytes in C3-deficient animals ( Figs  4 and 5) . Thus, the addition of anti-band 3 antibodies did not significantly accelerate the clearance of untreated or diamide-treated, labeled erythrocytes in C3-deficient guinea pigs.
Effect of exogenous band 3 protein on erythrocyte clearance. To lower the endogenous concentration of anti-band 3 antibodies in normal guinea pigs, we injected 200 pg highly purified human band 3 protein 4 hours before infusing labeled erythrocytes. This pretreatment lowered the endoge- nous anti-band 3 antibody concentrations by about 50% at 4 to 24 hours, as assessed by a radioimmunoassay (see Materials and Methods). Administration of band 3 protein slightly delayed the clearance of erythrocytes when incubated with control IgG- (Fig 6A, B) . This effect of band 3 protein was not only seen with mildly oxidized labeled cells, but also with erythrocytes that were heavily oxidized by exposure to diamide. The delay of clearance introduced by injecting band 3 protein was abolished by the presence of exogenous antiband 3 antibodies, irrespective of whether erythrocytes were exposed to diamide or not (Fig 6C, D) . These results suggest that exogenous band 3 protein modulated the endogenous anti-band 3 antibody concentration.
DISCUSSION
Recent in vitro studies from our laboratory and others indicate that human naturally occurring anti-band 3 autoantibodies are involved in the recognition, opsonization, and phagocytosis of altered and senescent erythrocyte^.'^"^ The herein described experiments with guinea pigs indicate that human naturally occurring anti-band 3 antibodies can accelerate the extravascular clearance of labeled and oxidatively stressed erythrocytes in the presence of functional complement in vivo. In addition, a delayed clearance of labeled and oxidatively stressed erythrocytes was observed by prior administration of band 3 protein and further supports a tissue homeostatic role of anti-band 3 antibodies in the clearance of altered and senescent erythrocytes. Purified human anti-band 3 autoantibodies bound specifically to guinea pig band 3 protein on intact erythrocytes and on blots from electrophoretically separated erythrocyte membrane proteins. Its binding affinity was less than that previously described for human band 3 protein," presumably because of species differences in the structure of band 3 protein, The degree of binding of human anti-band 3 antibodies to erythrocytes was dependent on the antibody concentration. Therefore, anti-band 3 antibodies likely bind to preexisting antigenic sites on erythrocytes rather than requiring chemical modification for binding.l5*l6 The plasma concentration of anti-band 3 antibodies in healthy humans and guinea pigs is more than two orders of magnitude below saturation for these antibodies, with a known association constant of 5 X lo6 to 7 X lo6 Wmol human band 3 protein"; therefore, the autoantibody concentration appears to be limiting and thereby influences the clearance of erythrocytes. The estimated number of bound antibodies was 22 to 35 molecules per cell at 5 p g / d anti-band 3 antibody concentration, which seems, in the presence of complement, sufficient to enhance the clearance of erythrocytes for an antibody that preferentially forms C3b-IgG c~mplexes.~' A similar number of complement fixing sites per cell opsonized with an induced antibody resulted in a half-life of less than 10 minutes in guinea Similar to studies with human erythrocytes," exposure to diamide, an oxidative agent, increased the binding of human anti-band 3 antibodies to erythrocytes from guinea pigs. There was not only binding to band 3 protein, but also to high-molecular-weight band 3 protein complexes that may represent band 3 protein oligomers and band 3 protein-hemo-1925 globin adducts. Oligomerization favors bivalent binding of antibodies and thereby reduces its dissociation by a factor of 100 to l,000~s47 This diamide-induced increased binding of anti-band 3 antibodies likely contributed to the accelerated clearance of oxidatively damaged erythrocytes, and because membrane changes induced by oxidative agents are similar to alterations observed in senescent erythrocytes, these mechanisms may play an important role in the clearance of aged and altered erythrocytes.4* The diamide treatment and oxidative damage by the iodination procedure may have had an additive effect on the clearance of erythrocytes, and other erythrocyte alterations affecting the clearance rate cannot be excluded. The diamide treatment and/or labeling procedure may have rendered erythrocytes more sensitive to complement by depleting them of glycosylphatidyl-inositol-anchored proteins, in the same manner as the decay accelerating factor (protects from C3b deposition) or the homologous restriction factor (prevents autologous cell l~sis)."~ As both proteins are lost in the form of vesicles from calcium-loaded and adenosine triphosphate-depleted human erythrocyte^,^^^^^ our incubation conditions with calcium-free, glucose-containing medium should have prevented their depletion.
Although erythrocyte clearance has not specifically been studied in guinea pigs, studies in rats," rabbits:3 and hypertransfused mices4 indicate that the mechanism involved in recognition and clearance of senescent erythrocytes is similar in rodents and other mammals, including human^. For personal use only. on October 27, 2017. by guest www.bloodjournal.org From observe the clearance of untreated and diamide-exposed erythrocytes in the same animal. In addition, elution of chromium label from erythrocytes was known to be considerable in guinea pigs,33 but negligible with surface iodination as shown in this study. Irrespective of the iodine isotope, the apparent half-life of labeled (autologous or allogeneic) erythrocytes in guinea pigs was approximately 8 days, comparable with that reported for chromium-labeled cells,33 but about five times shorter than the expected half-life based on cohort labeling.# The rapid clearance of iodinated erythrocytes may be caused by radical formation in the isotope solution, which mildly altered the cells. The alterations by labeling alone did not change the in vitro deformability of erythrocytes and did not generate SS-linked band 3 oligomers, but clearly induced cell water loss when labeled cells were further exposed to diamide, thus making these cells denser and less deformable.
When untreated or diamide-treated, labeled erythrocytes were incubated with anti-band 3 antibodies, their clearance was accelerated in normal guinea pigs compared with cells preincubated with anti-band 3-depleted IgG (IgG-control). By comparing the effect of anti-band 3 antibodies with that of an identical amount of IgG depleted of anti-band 3 antibodies, the possibility of an accelerated clearance by guinea pig antibodies to human IgG molecules or an unspecific activation of the phagocyte system appears unlikely. In a recent study:5 up to 600 mg/kg/d of human IgG administered to guinea pigs neither mounted a severe immune complex disease nor a Forssmann-like shock syndrome, thereby ruling out preexisting strong anti-human IgG reactivity. Furthermore, because these experiments were of short duration (less than 5 days), induced antibodies against human IgGs could not have developed and interfered here. Although the effect of anti-band 3 antibodies was significant, the change in clearance of untreated and diamide-treated cells was small. This may in part be explained by (1) the lower binding of human anti-band 3 antibodies to band 3 protein of erythrocytes from guinea pigs compared with human beings, (2) the single administration of a near physiologic concentration of antiband 3 antibody, and/or (3) the endogenous plasma antiband 3 antibody content. In fact, prior administration of purified human band 3 protein in normal guinea pigs lowered the plasma concentration of anti-band 3 antibodies and thereby delayed the clearance of labeled erythrocytes. Although these data are the first evidence of an in vivo effect of anti-band 3 antibodies on the clearance by labeled, untreated and diamide-exposed oxidized erythrocytes in normal guinea pigs, future studies are needed to further elucidate the homeostatic role of anti-band 3 antibodies on the removal of senescent erythrocytes in health, as well as removal of altered cells in disease.
A major advantage of choosing guinea pigs was the availability of a C3-deficient strain,35 which allowed us to study the in vivo involvement of complement in the anti-band 3 antibody-mediated clearance of erythrocytes. Complement component-3 -deficient guinea pigs have immunologically normal amounts of C3, but greater than 90% of it is functionally impaired by an inability of the nascent C3b to form covalent bond^.^' This dysfunction is apparently not caused by a mutation in the amino acid sequence of C3, but probably stems from a cotranslational or posttranslational defect in C3.36 These C3-deficient guinea pigs were stunted but not markedly susceptible to infection," and the mean survival of labeled and untreated or diamide-treated erythrocytes was similar in deficient and normal healthy guinea pigs.
Interestingly, in contrast to the accelerating effect of human anti-band 3 antibody on the clearance of erythrocytes in normal healthy guinea pigs, administration of these NOAs did not augment the erythrocyte clearance in C3-deficient guinea pigs in these short-term experiments. This finding suggests that the low affinity human anti-band 3 antibodies only gain in vivo functionality in the presence of active complement, as previously suggested by the enhanced in vitro phagocytosis of human erythrocytes exposed to complement'* and the ability of anti-band 3 antibodies to preferentially form C3b-IgG complexes,25 which are strong opsonins and nucleate alternative C3 convertase,I7 thereby leading to further C3 deposition and enhanced phagocytosis. Thus, in C3-deficient guinea pigs, the concentration of active C3 was apparently too low to facilitate an anti-band 3 antibody-mediated clearance of erythrocytes.
The described in vivo activities of anti-band 3 NOAs suggest that the specificity of these antibodies, their preferred binding to band 3 protein clusters, and their unique ability to mobilize complement C3b deposition assure a highly controlled clearance of a specifically altered group of target erythrocytes. Although the selective clearance of altered and senescent erythrocytes may well represent their main function, these anti-band 3 antibodies may also regulate the clearance of other cells that express band 3 proteins. Other NOAs have also been implicated in the clearance of erythrocytes. In particular, naturally occurring antispectrin autoantibodies have been found to be associated with oxidatively stressed erythrocytes and erythrocytes from patients with hemoglobinopathie~.~'.~~-~' However, human antispectrin antibodies appear to be functionally inefficient because they lack an affinity for C3" and, therefore, do not preferentially form C3b-IgG complexes in contrast with anti-band 3 antibodies." Furthermore, antispectrin antibodies belong to a group of cytophilic IgG molecules that associate unspecifically with erythrocytes, presumably via negatively charged sialic acid residues of glycophorin rather than spectrin on the surface of erythrocyte membranes,m-6z thus making a key role of antispectrin antibodies in the clearance of erythrocytes unlikely.
